City Holding CO Bio Rad Laboratories, Inc. Transaction History

City Holding CO

$641 Million
Q1 2024

A detailed history of City Holding CO transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, City Holding CO holds 52 shares of BIO stock, worth $14,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 62 16.13%

Holding current value

$14,296

Previous $20,000 15.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$304.11 - $351.99 $3,041 - $3,519	-10 Reduced 16.13%	52 $17,000
Q4 2023 Jan 10, 2024	SELL	$269.37 - $365.04 $64,379 - $87,244	-239 Reduced 79.4%	62 $20,000
Q3 2023 Oct 13, 2023	SELL	$350.25 - $422.63 $176,526 - $213,005	-504 Reduced 62.61%	301 $107,000
Q2 2023 Jul 13, 2023	SELL	$359.49 - $486.4 $208,504 - $282,112	-580 Reduced 41.88%	805 $305,000
Q1 2023 Apr 17, 2023	BUY	$418.69 - $503.0 $48,149 - $57,845	115 Added 9.06%	1,385 $663,000

Q4 2022 Jan 27, 2023	SELL	$351.71 - $456.01 $5,275 - $6,840	-15 Reduced 1.17%	1,270 $0
Q3 2022 Oct 12, 2022	BUY	$412.59 - $563.26 $10,314 - $14,081	25 Added 1.98%	1,285 $536,000
Q2 2022 Jul 08, 2022	BUY	$463.67 - $597.16 $23,183 - $29,858	50 Added 4.13%	1,260 $624,000
Q1 2022 Apr 15, 2022	BUY	$524.57 - $735.42 $70,816 - $99,281	135 Added 12.56%	1,210 $681,000
Q4 2021 Mar 11, 2022	BUY	$708.84 - $794.68 $209,107 - $234,430	295 Added 37.82%	1,075 $673,000
Q3 2021 Oct 15, 2021	BUY	$657.71 - $825.77 $338,720 - $425,271	515 Added 194.34%	780 $582,000
Q2 2021 Jul 15, 2021	BUY	$576.64 - $649.04 $152,809 - $171,995	265 New	265 $171,000

Others Institutions Holding BIO

# of Institutions

489

Shares Held

17.8M

Call Options Held

44.9K

Put Options Held

79.7K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.77B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of City Holding CO, based on Form 13F filings with the SEC.

News

Stay updated on City Holding CO with notifications on news.

Account